Evaxion A (EVAX) Net Cash Flow Growth (1y) (2021 - 2022)

Evaxion A (EVAX) Net Cash Flow Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - 198.34%
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn 467.41%
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - -14,223.53%
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn 453.08%
9 Abivax 93.46 Bn 93.46 Bn - -
10 Regeneron Pharmaceuticals 63.55 Bn 54.80 Bn 3.31 Bn -125.22%

Historic Data

Download Data
DateValue
Jun 30, 2022 -143.25%
Mar 31, 2022 -102.91%
Sep 30, 2021 462.31%
Jun 30, 2021 337.71%
Mar 31, 2021 785.14%